신경학 진단 및 모니터링 기기 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Neurology Diagnostic and Monitoring Devices Market size is expected to reach USD 17.55 Billion in 2034 from USD 8.77 Billion (2025) growing at a CAGR of 8.01% during 2026-2034.

The Global Neurology Diagnostic and Monitoring Devices Market is experiencing strong growth due to the rising prevalence of neurological disorders such as epilepsy, Parkinson's disease, Alzheimer's disease, and stroke. Increasing awareness regarding early diagnosis and continuous monitoring has driven demand for advanced imaging and neuro-monitoring systems. Technological advancements in EEG, EMG, and brain imaging devices are improving diagnostic accuracy and patient outcomes. Expanding healthcare infrastructure and growing geriatric populations worldwide are further accelerating market expansion.

Key growth drivers include increasing healthcare expenditure, adoption of minimally invasive diagnostic tools, and the integration of AI-based analytics in neurological assessments. Hospitals and specialty clinics are investing in portable and wearable monitoring devices for real-time patient tracking. Additionally, research initiatives focused on understanding neurodegenerative diseases are supporting demand for advanced diagnostic platforms. Government funding and favorable reimbursement policies in developed regions also contribute significantly to market growth.

Looking ahead, the market is expected to benefit from continuous innovation in digital health technologies and remote monitoring solutions. The development of compact, wireless neurodiagnostic systems will enhance accessibility in emerging markets. Growing telemedicine adoption and personalized treatment approaches will further expand demand. As neurological disorders continue to rise globally, the need for accurate and efficient diagnostic and monitoring devices will sustain long-term market growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Device Type

• Electroencephalogram (EEG) Systems
• Magnetic Resonance Imaging (MRI) Systems
• Computed Tomography (CT) Scanner
• Position Emission Tomography (PET) System
• Ultrasound Imaging Systems
• Others

By Indication

• Neurodegenerative Disease
• Epilepsy
• Stroke
• Others

By End-user

• Hospitals and Surgery Centers
• Neurology Centers
• Ambulatory Care Centers
• Diagnostic Laboratories & Imaging Centers
• Research Laboratories & Academic Institutes

COMPANIES PROFILED

• GE Healthcare, Neurosoft, Canon Medical Systems Corporation Canon Inc, Fujifilm Holding Corporation, Koninklijke Philips NV, Siemens Healthineers AG, Shimadzu Corporation, United Imaging Healthcare Co Ltd, Hologic Inc, Esaote SpA
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL NEUROLOGY DIAGNOSTIC AND MONITORING DEVICES MARKET: BY DEVICE TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Device Type
• 4.2. Electroencephalogram (EEG) Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Magnetic Resonance Imaging (MRI) Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Computed Tomography (CT) Scanner Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Position Emission Tomography (PET) System Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Ultrasound Imaging Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL NEUROLOGY DIAGNOSTIC AND MONITORING DEVICES MARKET: BY INDICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Indication
• 5.2. Neurodegenerative Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Epilepsy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Stroke Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL NEUROLOGY DIAGNOSTIC AND MONITORING DEVICES MARKET: BY END-USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-user
• 6.2. Hospitals and Surgery Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Neurology Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Ambulatory Care Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Diagnostic Laboratories & Imaging Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Research Laboratories & Academic Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL NEUROLOGY DIAGNOSTIC AND MONITORING DEVICES MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Device Type
  • 7.2.2 By Indication
  • 7.2.3 By End-user
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Device Type
  • 7.3.2 By Indication
  • 7.3.3 By End-user
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Device Type
  • 7.4.2 By Indication
  • 7.4.3 By End-user
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Device Type
  • 7.5.2 By Indication
  • 7.5.3 By End-user
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Device Type
  • 7.6.2 By Indication
  • 7.6.3 By End-user
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL NEUROLOGY DIAGNOSTIC AND MONITORING DEVICES INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 GE Healthcare
  • 9.2.2 Neurosoft
  • 9.2.3 Canon Medical Systems Corporation (Canon Inc.)
  • 9.2.4 Fujifilm Holding Corporation
  • 9.2.5 Koninklijke Philips N.V
  • 9.2.6 Siemens Healthineers AG
  • 9.2.7 Shimadzu Corporation
  • 9.2.8 United Imaging Healthcare Co. Ltd
  • 9.2.9 Hologic Inc
  • 9.2.10 Esaote SpA